Cognito’s OVERTURE trial demonstrated significant ‘time saved’ in functional and cognitive decline at both six and 18 months.

Michigan Advanced Psychiatry pioneers FDA-approved neuromodulation therapies like TMS, IV ketamine, and Spravato to treat resistant mental health conditions, offering fast, effective alternatives for ...

For work identifying a novel therapeutic target to improve walking after SCI, Newton Cho is the 2025 winner of the Science & PINS Prize for Neuromodulation. The prize rewards innovative research that ...

Am J Psych：一种实验性的SAINT抑郁症疗法或能有效治疗近80%的抑郁症患者！ SAINT 抑郁症 疗法 磁脉冲定位 神经回路 来源：本站原创 2021-11-09 21:50 来自 ...

A Cleveland Clinic psychiatrist explains how ketamine therapy is transforming depression treatment—and why it works when ...

Understanding mental illness requires understanding psychiatric disorder causality. New brain research explores this in ...

StickTronics and the shift to personalized, portable healthcare: Neeraj Nitin Jadhav Thursday, July 31, 2025, 08:00 Hrs [IST] Globally the prevalence of chronic ...

The Science & PINS Prize for Neuromodulation is a highly competitive award that recognizes scientists for their outstanding contributions in neuromodulation research. Neuromodulation is any form of ...

CVRx, Inc. (NASDAQ: CVRX) ('CVRx'), a commercial-stage medical device company focused on developing, manufacturing and ...

The current neuromodulation market has an estimated value of $5.8 billion, with over 50% of the value given by the SCS sector.